BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agentsPaul B. Mullan, D. Paul Harkin, Paula M. Gilmore et al.|Oncogene|2001Cited by 153
Activation of MAPK signalling results in resistance to saracatinib (AZD0530) in ovarian cancerNiamh McGivern, Nuala McCabe|Oncotarget|2017Cited by 32